Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...

Price transparency compliance is often “in-form” rather than “in-spirit,” with many machine-readable files failing to provide complete, accurate, and usable drug pricing data. Reform priorities ...

MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...

Recommendation is based on peer-reviewed clinical data supporting long-term effectiveness and safety durability in patients with papillary-only disease treated with ANKTIVA plus BCG1.CULVER CITY, ...

One of the most critical revelations from the NCI-K is that late diagnosis is often caused by a lack of follow-up. Patients frequently present early at local clinics, but because of poor paper-based ...

Good afternoon, and thank you for joining the Inovio Fourth Quarter and Full Year 2025 Financial Results Conference Call.

Image in Creative Commons. In 1967, Hungarian scientist Endre Mester tried to cure skin cancer in mice using a low-powered ruby laser. He failed to stop ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a clinical-stage biotechnology company developing a pipeline of ...

Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.

Grey’s Anatomy calls out government cuts to cancer research as Dr. Bailey blames “bureaucratic stupidity” for Katie’s ...